Economy News Third Rock-backed Maze Therapeutics reveals profit in US IPO filing by January 7, 2025 written by January 7, 2025 Post Content 0 FacebookTwitterPinterestEmail previous post Exxon Mobil signals Q4 earnings to drop versus prior quarter next post Exxon signals weaker performance across the board to hurt Q4 profits Related News Fed minutes show Wall Street pushed back expected... January 8, 2025 Bond market selloff alarms global investors as ‘tantrum’... January 8, 2025 Fed eyes slower rate cuts on worries about... January 8, 2025 France can’t stray far from 5% deficit –... January 8, 2025 Yellen says COVID spending may have contributed ‘little... January 8, 2025 Treasury yield surge reflects expectations of more long-term... January 8, 2025 ECB could reach neutral rate by summer, Villeroy... January 8, 2025 Greenland, gas heaters and the Gulf: Takeaways from... January 8, 2025 Greenland independence is possible but joining the US... January 8, 2025 Greenland independence is possible but joining the US... January 8, 2025
